Your browser doesn't support javascript.
loading
Hypercalcemia associated with isolated bone marrow sarcoidosis in a patient with underlying monoclonal gammopathy of undetermined significance: case report and review of literature.
Gubatan, John; Wang, Xiaohui; Louissaint, Abner; Mahindra, Anuj; Vanderpool, John.
Afiliación
  • Gubatan J; Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215 USA.
  • Wang X; Hallmark Health Medical Associates, Melrose-Wakefield Hospital, Reading, MA USA.
  • Louissaint A; Department of Pathology, Massachusetts General Hospital, Boston, MA USA.
  • Mahindra A; Division of Hematology and Oncology, University of California San Francisco Medical Center, San Francisco, CA USA.
  • Vanderpool J; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA USA.
Biomark Res ; 4: 18, 2016.
Article en En | MEDLINE | ID: mdl-27651903
ABSTRACT

BACKGROUND:

Bone marrow sarcoidosis is extremely rare. The association between sarcoidosis and lymphoproliferative disorders has been previously speculated, although the diagnosis of sarcoidosis often precedes any hematological derangements. CASE PRESENTATION Here, we report for the first time, a case of a 57-year-old Caucasian woman with a previous diagnosis of monoclonal gammopathy of undetermined significance (MGUS) developing hypercalcemia and renal failure with workup notable for isolated bone marrow sarcoidosis and not multiple myeloma as expected. The patient was successfully managed with prednisone taper therapy with resolution of her hypercalcemia and repeat bone marrow biopsies demonstrating resolving granulomas.

CONCLUSIONS:

Our case illustrates the diagnostic challenges associated with bone marrow sarcoidosis and suggest that chronic immune stimulation in the bone marrow in the setting of MGUS may be associated with the development of localized sarcoidosis. The long term consequences of steroid therapy targeting sarcoidosis in this patient with underlying MGUS remain unknown. Greater surveillance and closer followup is planned in light of the increased risk of malignant transformation of MGUS into multiple myeloma in the setting of bone marrow sarcoidosis.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Biomark Res Año: 2016 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Biomark Res Año: 2016 Tipo del documento: Article
...